Marko Anderluh
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 13
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 7
- Organic Chemistry top 2%
- Carbohydrate Chemistry and Synthesis 13
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 21
- Cancer therapeutics and mechanisms 15
- Immunology top 10%
- Galectins and Cancer Biology 13
- Immunotherapy and Immune Responses 8
-
- Neuropeptides and Animal Physiology 8
- Co-authors
- D. KikeljUrban ŠvajgerNataša ObermajerMarija Sollner DolencTihomir TomašičAndrija ŠmelcerovićJanez IlašGordana Kocić
- Journals
- ChemMedChem (9 papers)European Journal of Medicinal Chemistry (9 papers)Journal of Medicinal Chemistry (7 papers)
- Partner nations
- SloveniaSerbiaNetherlands
In The Last Decade
Marko Anderluh
102 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Molecular Medicine 147
- Toxicology 96
- Organic Chemistry 774
- Molecular Biology 1.2k
- Immunology 343
Countries citing papers authored by Marko Anderluh
This map shows the geographic impact of Marko Anderluh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Anderluh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Anderluh more than expected).
Fields of papers citing papers by Marko Anderluh
This network shows the impact of papers produced by Marko Anderluh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Anderluh. The network helps show where Marko Anderluh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marko Anderluh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 10 | |
| 16 | 2020 | 6 | |
| 17 | 2020 | 10 | |
| 18 | 2018 | 20 | |
| 19 | 2014 | 26 | |
| 20 | Synthesis of C6-ethylidene meropenem derivative with antimicrobial activity | 2009 | 4 |
About Marko Anderluh
Marko Anderluh is a scholar working on Molecular Medicine, Toxicology and Immunology, having authored 105 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (21 papers), Cancer therapeutics and mechanisms (15 papers), Antibiotic Resistance in Bacteria (13 papers), Carbohydrate Chemistry and Synthesis (13 papers), Galectins and Cancer Biology (13 papers), Neuropeptides and Animal Physiology (8 papers), Immunotherapy and Immune Responses (8 papers) and Bioactive Compounds and Antitumor Agents (7 papers). The work is most often cited by research in Molecular Medicine (147 citations), Toxicology (96 citations) and Organic Chemistry (774 citations). Marko Anderluh has collaborated with scholars based in Slovenia, Serbia and Netherlands. Frequent co-authors include D. Kikelj, Urban Švajger, Nataša Obermajer, Marija Sollner Dolenc, Tihomir Tomašič, Andrija Šmelcerović, Janez Ilaš, Gordana Kocić, Matjaž Jeras and Katarina Tomović. Their work appears in journals such as ChemMedChem, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.